382 related articles for article (PubMed ID: 25940043)
1. Translating the genetics of cystic fibrosis to personalized medicine.
Corvol H; Thompson KE; Tabary O; le Rouzic P; Guillot L
Transl Res; 2016 Feb; 168():40-49. PubMed ID: 25940043
[TBL] [Abstract][Full Text] [Related]
2. [Challenges of personalized medicine for cystic fibrosis].
Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
[TBL] [Abstract][Full Text] [Related]
3. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.
Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449
[TBL] [Abstract][Full Text] [Related]
5. A new era of personalized medicine for cystic fibrosis - at last!
Quon BS; Wilcox PG
Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
[TBL] [Abstract][Full Text] [Related]
6. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.
Fanen P; Wohlhuter-Haddad A; Hinzpeter A
Int J Biochem Cell Biol; 2014 Jul; 52():94-102. PubMed ID: 24631642
[TBL] [Abstract][Full Text] [Related]
7. New treatments targeting the basic defects in cystic fibrosis.
Fajac I; Wainwright CE
Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Cystic Fibrosis with CFTR Modulators].
Tümmler B
Pneumologie; 2016 May; 70(5):301-13. PubMed ID: 26894479
[TBL] [Abstract][Full Text] [Related]
9. Genetics of Cystic Fibrosis: Clinical Implications.
Egan ME
Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
[TBL] [Abstract][Full Text] [Related]
10. Lumacaftor/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR.
Zhang W; Zhang X; Zhang YH; Strokes DC; Naren AP
Drugs Today (Barc); 2016 Apr; 52(4):229-37. PubMed ID: 27252987
[TBL] [Abstract][Full Text] [Related]
11. Discovery of CFTR modulators for the treatment of cystic fibrosis.
Lopes-Pacheco M; Pedemonte N; Veit G
Expert Opin Drug Discov; 2021 Aug; 16(8):897-913. PubMed ID: 33823716
[TBL] [Abstract][Full Text] [Related]
12. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD
EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis - an example of personalized and precision medicine.
Skov M; Hansen CR; Pressler T
APMIS; 2019 May; 127(5):352-360. PubMed ID: 30761610
[TBL] [Abstract][Full Text] [Related]
14. [Cystic fibrosis: molecular update and clinical implications].
Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation.
Arora K; Yarlagadda S; Zhang W; Moon C; Bouquet E; Srinivasan S; Li C; Stokes DC; Naren AP
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L364-74. PubMed ID: 27261451
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date.
Becq F
Drugs; 2010 Feb; 70(3):241-59. PubMed ID: 20166764
[TBL] [Abstract][Full Text] [Related]
17. New and emerging targeted therapies for cystic fibrosis.
Quon BS; Rowe SM
BMJ; 2016 Mar; 352():i859. PubMed ID: 27030675
[TBL] [Abstract][Full Text] [Related]
18. CFTR Folding: From Structure and Proteostasis to Cystic Fibrosis Personalized Medicine.
McDonald EF; Meiler J; Plate L
ACS Chem Biol; 2023 Oct; 18(10):2128-2143. PubMed ID: 37730207
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment.
Pettit RS
Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718
[TBL] [Abstract][Full Text] [Related]
20. CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.
Fernandez Fernandez E; De Santi C; De Rose V; Greene CM
Expert Rev Respir Med; 2018 Jun; 12(6):483-492. PubMed ID: 29750581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]